Back to Journals » Research Reports in Clinical Cardiology » Volume 4
Review
![Noteworthy Comment: The biology and current status of CETP inhibition as a therapeutic target are authoritatively presented in this re-evaluation. Anacetrapib, a potent CETP inhibitor, may prove to be a valuable addition to the clinician's armamentarium.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anacetrapib: potential for the prevention and treatment of coronary heart disease
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,836 | Dovepress* | 10,836+ | 3,398 | 14,234 | |
Totals | 10,836 | 3,398 | 14,234 | ||
*Since 4 April 2013 +Since July 2016 |
View citations on Google Scholar